Intellectual Property News & Topics - Secerna LLP

WAKIX (1)

A to Z: Drugs in Highlight: W is for WAKIX®

News A to Z Feature 08/05/2025

Our A to Z series highlights WAKIX® (from Bioprojet Pharma) which is used to treat narcolepsy in adults, adolescents and children from 6 years of age. The active substance in WAKIX® is pitolisant. Pitolisant works by blocking histamine from attaching to the histamine H3 receptor on nerve cells.

Read more

IMBRUVICA

News, A to Z Feature 30/01/2025

A to Z: Drugs in Highlight: I is for IMBRUVICA®

Secerna Website Images 2025 (4)

Industry news, News 27/01/2025

Unlocking Faster Cancer Treatments: The Power of Project Orbis

Secerna Website Images 2025 (3)

Industry news, News, Team news 24/01/2025

Secerna Expands Life Sciences Team with the Addition of Trainee Patent Attorney

HERCEPTIN

News, A to Z Feature 23/01/2025

A to Z: Drugs in Highlight: H is for HERCEPTIN®

EPO 2021

European, News 21/01/2025

Added Matter Objections at the European Patent Office (EPO)

Secerna Website Images 2025

Industry news, News 20/01/2025

Thatchers vs Aldi: A Victory in the Battle Against Cloudy Lemon Cider Dupe

Generative AI

Industry news, News 17/01/2025

USPTO Announces AI Strategy to Empower Responsible Innovation

GILENYA

News, A to Z Feature 16/01/2025

A to Z: Drugs in Highlight: G is for GILENYA®

Jason Boakes And Sam Turton Secerna LLP (2)

News, Team news, Careers 14/01/2025

Secerna Strengthens Team with Addition of Trade Mark Attorney

1 2 3 4 5 6 7 8 9 10